However, it is proposed that HLA-G expression on tumor B cells, as in Hodgkin lymphoma, may be potentially beneficial in controlling tumor cell proliferation, as in vitro HLA-G binding to ILT2 on B cell surface has been shown to cause inhibition of B cell proliferation, differentiation and antibody secretion [41]. This evidence concerns the gene HLA-G and Hodgkins lymphoma.